CN105256038A - PCR detecting primer and kit for genes of heterocephalus-glaber cell factor IL-6 - Google Patents

PCR detecting primer and kit for genes of heterocephalus-glaber cell factor IL-6 Download PDF

Info

Publication number
CN105256038A
CN105256038A CN201510713237.9A CN201510713237A CN105256038A CN 105256038 A CN105256038 A CN 105256038A CN 201510713237 A CN201510713237 A CN 201510713237A CN 105256038 A CN105256038 A CN 105256038A
Authority
CN
China
Prior art keywords
primer
seqidno
pcr
naked mole
cytokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510713237.9A
Other languages
Chinese (zh)
Inventor
崔淑芳
程继帅
肖邦
林丽芳
赵善民
汤球
孙伟
余琛琳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN201510713237.9A priority Critical patent/CN105256038A/en
Publication of CN105256038A publication Critical patent/CN105256038A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a technology for detecting genes of a heterocephalus-glaber cell factor IL-6, belongs to the field of biotechnology detection, and provides a PCR detecting primer and kit for genes of the heterocephalus-glaber cell factor IL-6. The forward primer is 5'-ACGCTAGTCCTCCACGAT-3', and the reverse primer is 5'-GGTTGTTTAACATTGCCTTT-3'. The invention further provides a method for detecting the genes of the heterocephalus-glaber cell factor IL-6. The method includes the steps that total mRNA of macrophage of heterocephalus glaber is extracted and subjected to inverse transcription to form cDNA which serves as a detected sample, detection is carried out with a Real-time PCR method, the expression level of the IL-6 is obtained, and the expression of the genes of the IL-6 is quantitatively and qualitatively detected with a PCR detection technology. The primer and the method are simple, rapid and suitable for use and popularization.

Description

Naked mole cytokine IL-6 gene PCR detects primer and detection kit
Technical field
The invention belongs to field of biological technology detection, be specifically related to naked mole cytokine IL-6 technique of gene detection.
Background technology
Naked mole (Heterocephalusglaber, nakedmolerat, NMR) be a kind of special rodent, its life-span is the longest in rodent, the oldest individuality is more than 3O year, 2O year about animal bodies state generally good, the sign that the naked mole performance more than 25 years old is weak, mostly dies from senile disease; The situation that naked mole dies from cancer never finds, anatomical results also never finds tumour, has certain anticancer mechanism.The exploration of naked mole antitumor properties mechanism opens new chapter by giving the research of tumour.At present, a lot of bases, clinical and EPDML research are verified, and inflammation is one clearly can lead oncogenic Hazard Factor.The mechanism that etiology causes certain specific tumors to be fallen ill also is not suitable for other cancer kinds, but pathogenesis is in essence all identical, is exactly induction and the maintenance of inflammation.Interleukin 6 (interleukin-6, IL-6) (the GeneID:3569 of people IL-6, the GeneID:16193 of mouse IL-6) can break up and produce antibody by elicit B cell, and inducing T cell activation is bred, differentiation, participate in the immunne response of body, be Inflammatory response inspire agent.Therefore, the mechanism disclosing the antitumor properties that it may exist is conducive to the detection of naked mole IL-6 gene expression dose.
At present, due to naked mole sexual maturity, (Female sexual maturation age is 228 days, is 6.5 times of mouse evening; Male sexual maturation age is 12 months, is 8.1 times of mouse), the Gestation period long (68 days is 3.2 times of mouse), and wild naked mole lives in sweltering heat, area, dry East Africa, throughout one's life in the underground of dark, is difficult to catch.Therefore, the number of naked mole is relatively less, greatly constrains its applied research.The cell of vitro culture has division and multiplication capacity, strong adaptability, easily the feature such as cultivation, and therefore, somatic cell culture technology can solve naked mole research material and to originate less problem.
At present, in research, the detection of cytokine IL-6 genetic expression is carried out mainly through ELISA detection kit, in the method, need using specific antibody, but at present still not for the specific antibody of naked mole.
Summary of the invention
In order to solve above-mentioned the deficiencies in the prior art, the invention provides primer and the detection kit of naked mole cytokine IL-6 gene PCR detection, utilize PCR detection technique quantitatively and qualitatively to detect IL-6 genetic expression, simple and fast, is applicable to promoting the use of.
A first aspect of the present invention, provides a kind of naked mole cytokine IL-6 gene PCR and detects primer:
Forward primer: 5 '-ACGCTAGTCCTCCACGAT-3 ' (SEQIDNO:1),
Reverse primer: 5 '-GGTTGTTTAACATTGCCTTT-3 ' (SEQIDNO:2).
A second aspect of the present invention, provides a kind of naked mole cytokine IL-6 gene PCR detection kit, and its detection primer is:
Forward primer: as shown in SEQIDNO:1,
Reverse primer: as shown in SEQIDNO:2.
Above-mentioned naked mole cytokine IL-6 gene PCR detection kit, also comprises:
2×SYBRPremixExTaq5ul,ROXReferenceDye(50×)0.2ul,ddH 2O3.6ul。
Preferably, one of the present invention naked mole cytokine IL-6 gene PCR detection kit, comprising:
Forward primer: as shown in SEQIDNO:1,
Reverse primer: as shown in SEQIDNO:2;
2×SYBRPremixExTaq5ul;
ROXReferenceDye(50×)0.2ul;
ddH 2O3.6ul。
A third aspect of the present invention, provide a kind of detection method of naked mole cytokine IL-6 gene, described detection method utilizes above-mentioned specific detection primer; Or utilizing above-mentioned detection kit, described detection method comprises the steps:
Extract total mRNA of naked mole Macrophage Cell, and reverse transcription is cDNA as detection sample, use Real-timePCR method to detect, draw the expression level of IL-6, primer sequence is as follows:
Forward primer: as shown in SEQIDNO:1,
Reverse primer: as shown in SEQIDNO:2;
The detection method of above-mentioned naked mole cytokine IL-6 gene, concrete detecting step is:
1) mRNA is extracted:
The naked mole scavenger cell of separation and Culture, extract cell total rna, and reverse transcription is cDNA.
2) real-time fluorescence quantitative PCR reaction system 10ul is prepared
Get step 1) middle cDNA template 0.8ul, 2 × SYBRPremixExTaq5ul, PCR forward primer (10 μ Μ) 0.2ul, PCR reverse primer (10uM) 0.2ul, ROXReferenceDye (50 ×) 0.2ul, ddH 2o3.6ul.Negative control is set.
3) PCR reaction is carried out
Reaction cycle is set to: 95 DEG C of 30s cycles stage of holding stage, 95 DEG C of 5s, 60 DEG C of 34s, 72 DEG C of 30s, 40 circulations; Solubility curve stage 95 DEG C of 15s, 60 DEG C of 1min, 95 DEG C of 15s, 40 circulations.
Technique effect of the present invention is as follows:
Primer used detects for the mRNA level in-site of naked mole IL-6, extract total mRNA of naked mole Macrophage Cell, and reverse transcription is that cDNA is as detection sample, Real-timePCR method is used to detect, draw the expression level of IL-6, as judging the basis for estimation that naked mole IL-6 genetic expression changes, there is good specificity and practicality.
Accompanying drawing illustrates:
Fig. 1 is the melting curve that embodiment 1 real-time fluorescence quantitative PCR detects;
Fig. 2 is the amplification curve that embodiment 1 real-time fluorescence quantitative PCR detects;
Fig. 3 is (b, c, melting curves d) detected with primer sequence (a) real-time fluorescence quantitative PCR in the present invention of other three pairs of primers in embodiment 2.
Embodiment
Concrete the present invention is further illustrated with accompanying drawing in conjunction with the embodiments, but enforcement of the present invention is not limited in this.
Embodiment 1:
MRNA sequence according to mole cytokine IL-6 gene naked on GeneBank carries out design of primers, and primer sequence is as follows:
Forward primer: 5 '-ACGCTAGTCCTCCACGAT-3 ' (SEQIDNO:1)
Reverse primer: 5 '-GGTTGTTTAACATTGCCTTT-3 ' (SEQIDNO:2).
Concrete detecting step is as follows:
1) mRNA is extracted:
The naked mole scavenger cell of separation and Culture, A group is blank group, is labeled as 1,2; B group is experimental group, uses virus mimics polyI:C stimulating expression of macrophage, is labeled as 3-6.Extract cell total rna (TaKaRaRNAisoPlus) (TangXL respectively, XinY, etal.MetabolicCharacteristicsandResponsetoHighAltitudein Phrynocephaluserythrurus (Lacertilia:Agamidae), aLizardDwellatAltitudesHigherThanAnyOtherLivingLizardsin theWorld.PLoSOne.2013Aug7; , and reverse transcription is cDNA (FastQuantRTKit (WithgDNase) (KR106), purchased from Tian Gen biochemical technology company limited) 8 (8): e71976.).
2) real-time fluorescence quantitative PCR reaction system 10ul is prepared
Get step 1) middle cDNA template 0.8ul, 2 × SYBRPremixExTaq5ul, PCR forward primer (PCRForwardprimer) (10 μ Μ) 0.2ul, PCR reverse primer (PCRreverseprimer) (10uM) 0.2ul, ROXReferenceDye (50 ×) 0.2ul, redistilled water (ddH 2o) 3.6ul.Negative control is set.
3) PCR reaction is carried out
Reaction cycle is set to: holding stage (Holdingstage) 95 DEG C of 30s; Cycle stage (cyclingstage) 95 DEG C of 5s, 60 DEG C of 34s, 72 DEG C of 30s, 40 circulations; Solubility curve stage (Meltcurvestage) 95 DEG C of 15s, 60 DEG C of 1min, 95 DEG C of 15s, 40 circulations.
Fig. 1 melting curve represents the specificity (in figure, curve 1,2 represents blank group, and curve 3,4,5,6 represents polyI:C stimulating group) of IL-6 factor primer amplification; Fig. 2 amplification curve represents the real-time fluorescence quantitative PCR amplification curve of blank group (1,2) and polyI:C stimulating group (3,4,5,6).
In the melting curve figure of Fig. 1 embodiment 1, all there is single peak value in all sample PCR reactions of detection, solvent temperature Tm value is 85.15 DEG C, illustrates that quantitative fluorescent PCR reacts IL-6 primer used and has good specificity.In Fig. 2 amplification curve, ordinate zou Δ Rn refers to standard indicator signal value and deducts baseline signal value, and X-coordinate represents cycle number, as seen from the figure, what the Δ Rn value of all samples detected all counted up at PCR circulating ring advances into plateau, illustrates that real-time fluorescence quantitative PCR reaction result is effective.
Embodiment 2
MRNA sequence information according to mole cytokine IL-6 gene naked on GeneBank designs other three kinds of primers simultaneously:
b:
Forward primer 5 '-CGTCAAGTAAGCCAACAA-3 ' (SEQIDNO:3),
Reverse primer 3 '-GGAGGACTAGCGTAAACAG-5 ' (SEQIDNO:4).
c:
Forward primer: 5 '-TTACGCTAGTCCTCCACG-3 ' (SEQIDNO:5),
Reverse primer: 3 '-GGTTGTTTAACATTGCCTTT-5 ' (SEQIDNO:2).
d:
Forward primer: 5 '-ATTTCAGGGCTGATACGA-3 ' (SEQIDNO:6),
Reverse primer: 3 '-TTCAGTTCCTGGACATCG-5 ' (SEQIDNO:7).
Concrete detecting step is as follows:
1) mRNA is extracted:
The naked mole scavenger cell of separation and Culture, extract cell total rna (TaKaRaRNAisoPlus), and reverse transcription is cDNA (FastQuantRTKit (WithgDNase) (KR106), purchased from Tian Gen biochemical technology company limited).
2) real-time fluorescence quantitative PCR reaction system 10ul is prepared
Get step 1) middle cDNA template 0.8ul, 2 × SYBRPremixExTaq5ul, PCRForwardPrimer (10 μ Μ) 0.2ul, PCRReversePrimer (10uM) 0.2ul, ROXReferenceDye (50 ×) 0.2ul, ddH2O3.6ul.Negative control is set.
3) PCR reaction is carried out
Reaction cycle is set to: Holdingstage95 DEG C of 30s; Cyclingstage95 DEG C of 5s, 60 DEG C of 34s, 72 DEG C of 30s, 40cycles; Meltcurvestage95 DEG C of 15s, 60 DEG C of 1min, 95 DEG C of 15s, 40 circulations.
Fig. 3 melting curve represents three pairs of primers (b, c, melting curve design sketch d) reacted with the PCR of the primer (a) in invention respectively.As shown in the figure, (melting curve of b, c, d) PCR reaction does not all have unique melting temperature (Tm) Tm to three pairs of primers, illustrates that primer does not have specificity, there is nonspecific amplification, thus can not be used for the expression level judging gene mRNA.And the melting curve of primer (a) in the present invention has single peak value, illustrate that this primer has good specificity, may be used for the expression level change judging IL-6 factor mRNA, reliable results.
Below the preferred embodiment of the invention is illustrated, but the invention is not limited to described embodiment, those of ordinary skill in the art also can make all equivalent modification or replacement under the prerequisite without prejudice to the invention spirit, and these equivalent modification or replacement are all included in the application's claim limited range.

Claims (6)

1. a naked mole cytokine IL-6 gene PCR detects primer:
Forward primer as shown in SEQIDNO:1,
Reverse primer is as shown in SEQIDNO:2.
2. a naked mole cytokine IL-6 gene PCR detection kit, its detection primer is:
Forward primer: as shown in SEQIDNO:1,
Reverse primer: as shown in SEQIDNO:2.
3. naked mole cytokine IL-6 gene PCR detection kit according to claim 2, also comprises:
2×SYBRPremixExTaq5ul,
50×ROXReferenceDye0.2ul,
ddH 2O3.6ul。
4. naked mole cytokine IL-6 gene PCR detection kit according to claim 2, comprising:
Forward primer: as shown in SEQIDNO:1,
Reverse primer: as shown in SEQIDNO:2;
2×SYBRPremixExTaq5ul;
50×ROXReferenceDye0.2ul;
ddH 2O3.6ul。
5. a detection method for naked mole cytokine IL-6 gene, it is characterized in that, described detection method comprises the steps:
Extract total mRNA of naked mole Macrophage Cell, and reverse transcription is cDNA as detection sample, use Real-timePCR method to detect, draw the expression level of IL-6, primer sequence is as follows:
Forward primer: as shown in SEQIDNO:1,
Reverse primer: as shown in SEQIDNO:2.
6. the detection method of naked mole cytokine IL-6 gene according to claim 5, it is characterized in that, concrete detecting step is:
A. mRNA is extracted:
The naked mole scavenger cell of separation and Culture, extract cell total rna, and reverse transcription is cDNA;
B. real-time fluorescence quantitative PCR reaction system 10ul is prepared:
Get cDNA template 0.8ul in steps A, 2 × SYBRPremixExTaq5ul, the PCR reverse primer 0.2ul of the PCR forward primer 0.2ul of 10 μ Μ, 10 μ Μ, 50 × ROXReferenceDye0.2ul, ddH 2o3.6ul; Negative control is set;
C. PCR reaction is carried out:
Reaction cycle is set to: 95 DEG C of 30s cycles stage of holding stage, 95 DEG C of 5s, 60 DEG C of 34s, 72 DEG C of 30s, 40 circulations; Solubility curve stage 95 DEG C of 15s, 60 DEG C of 1min, 95 DEG C of 15s, 40 circulations.
CN201510713237.9A 2015-10-28 2015-10-28 PCR detecting primer and kit for genes of heterocephalus-glaber cell factor IL-6 Pending CN105256038A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510713237.9A CN105256038A (en) 2015-10-28 2015-10-28 PCR detecting primer and kit for genes of heterocephalus-glaber cell factor IL-6

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510713237.9A CN105256038A (en) 2015-10-28 2015-10-28 PCR detecting primer and kit for genes of heterocephalus-glaber cell factor IL-6

Publications (1)

Publication Number Publication Date
CN105256038A true CN105256038A (en) 2016-01-20

Family

ID=55095963

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510713237.9A Pending CN105256038A (en) 2015-10-28 2015-10-28 PCR detecting primer and kit for genes of heterocephalus-glaber cell factor IL-6

Country Status (1)

Country Link
CN (1) CN105256038A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103409453A (en) * 2013-08-16 2013-11-27 四川卧龙国家级自然保护区管理局 Preparation method of recombinant panda IL-6 immunological adjuvant
CN103498005A (en) * 2013-10-24 2014-01-08 唐余龙 Il-6 gene pcr detection primer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103409453A (en) * 2013-08-16 2013-11-27 四川卧龙国家级自然保护区管理局 Preparation method of recombinant panda IL-6 immunological adjuvant
CN103498005A (en) * 2013-10-24 2014-01-08 唐余龙 Il-6 gene pcr detection primer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
林丽芳等: "Poly I:C刺激对裸鼹鼠体内自噬水平的影响", 《实验动物与比较医学》 *
林丽芳等: "裸鼹鼠外周血白细胞免疫相关因子mRNA表达水平的检测", 《实验动物与比较医学》 *

Similar Documents

Publication Publication Date Title
CN102154505B (en) Method and primers for detecting mi ribonucleic acid (miRNA) and application thereof
AU2018202963B2 (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
CN103382507B (en) 1 type and 3 type duck hepatitis A virus (HAV) single stage method dual RT-PCR detection kit, primer pair and method
CN102002494B (en) microRNA biomarker and application thereof
JP2017501719A (en) Nucleic acid detection method and kit
CN105506111B (en) Method for detecting CNV (CNV) marker of MAPK10 gene of Nanyang cattle and application of CNV marker
US20210292850A1 (en) Methylation modification-based tumor marker stamp-ep2
EP3916092A1 (en) Tumor marker stamp-ep5 based on methylated modification
CN105018638A (en) Detection and application of gastric carcinogenesis associated molecular marker IncRNA (long non-coding RNA) HOTTIP (HOXA transcript at the distal tip)
CN109593847B (en) Primer pair, kit and method for detecting stability of NR24 locus of microsatellite
US20220177973A1 (en) Methylation modification-based tumor marker stamp-ep6
CN109055564B (en) CircRNA marker for diagnosis and prognosis evaluation of chronic lymphocytic leukemia
CN103276099B (en) Primer and kit for fluorescent quatititive PCR (polymerase chain reaction) detection of helicobacter pylori
CN112239779A (en) Primer and kit for quickly identifying sex of egg-shaped pompano and application of primer and kit
CN105256038A (en) PCR detecting primer and kit for genes of heterocephalus-glaber cell factor IL-6
Sebestyén et al. Distinct miRNA expression signatures of primary and secondary central nervous system lymphomas
CN103173449B (en) Esophagus cancer postoperative early-stage recurrence and prognosis related miRNA marker and its application
CN103173450B (en) Esophagus cancer postoperative early-stage recurrence and prognosis related miRNA marker and its application
CN109628594B (en) One kind long-chain non-coding RNA relevant to liver cancer and its application
CN102899390A (en) Small cell lung cancer markers and their detection
CN103114092B (en) MiRNA marker associated with post-esophageal-cancer-operation early recurrence and prognosis and applications thereof
CN103966310A (en) Rapid detection kit and detection method for breast cancer susceptibility genes
CN110820051A (en) High-sensitivity fusion gene detection method and application thereof
WO2014093504A1 (en) Microrna biomarkers for graft versus host disease
CN103409544B (en) Application of primer to detection of false negative of polymerase chain reaction (PCR) of various organisms

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160120